Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma

Immunosuppression is a hallmark of pancreatic ductal adenocarcinoma (PDAC), contributing to early metastasis and poor patient survival. Compared to the localized tumors, current standard-of-care therapies have failed to improve the survival of patients with metastatic PDAC, that necessecitates explo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gautam, Shailendra K., Batra, Surinder K., Jain, Maneesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367391/
https://www.ncbi.nlm.nih.gov/pubmed/37488598
http://dx.doi.org/10.1186/s12943-023-01813-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367391/
https://www.ncbi.nlm.nih.gov/pubmed/37488598
http://dx.doi.org/10.1186/s12943-023-01813-y

Ejemplares similares